Primatene Mist Coming Back; Some Docs Concerned

By | February 4, 2019

Jason Shandell, president, Amphastar Pharmaceuticals Inc., Rancho Cucamonga, CA.

Sandy Walsh, spokeswoman, FDA.

FDA: “CDER Conversation: Safely Using the Newly Available OTC Asthma Inhaler Primatene Mist.”

James Li, MD, PhD, professor of medicine, Mayo Clinic, Rochester, MN; former president, American Academy of Allergy, Asthma & Immunology.

Dacia Morris, spokeswoman, American Thoracic Society, New York City.

Michael Blaiss, MD, executive medical director, American College of Allergy, Asthma, and Immunology; clinical professor, Medical College of Georgia, Augusta.

American Academy of Allergy, Asthma & Immunology: “Asthma Triggers and Management.”

CDC: “Asthma’s Impact on the Nation.” 

National Asthma Education & Prevention Program: “Guidelines for the Diagnosis and Management of Asthma.” Summary Report 2007.

WebMD Health